2017. Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study. Clinics. 72, 6 (Jun. 2017), 378–385. DOI:https://doi.org/10.6061/clinics/2017(06)08.